190 related articles for article (PubMed ID: 24309484)
1. Transfer of antigen from human B cells to dendritic cells.
Harvey BP; Raycroft MT; Quan TE; Rudenga BJ; Roman RM; Craft J; Mamula MJ
Mol Immunol; 2014 Mar; 58(1):56-65. PubMed ID: 24309484
[TBL] [Abstract][Full Text] [Related]
2. Editing antigen presentation: antigen transfer between human B lymphocytes and macrophages mediated by class A scavenger receptors.
Harvey BP; Quan TE; Rudenga BJ; Roman RM; Craft J; Mamula MJ
J Immunol; 2008 Sep; 181(6):4043-51. PubMed ID: 18768860
[TBL] [Abstract][Full Text] [Related]
3. A role for class A scavenger receptor in dendritic cell nibbling from live cells.
Harshyne LA; Zimmer MI; Watkins SC; Barratt-Boyes SM
J Immunol; 2003 Mar; 170(5):2302-9. PubMed ID: 12594251
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of antigen trafficking through scavenger receptor A.
Raycroft MT; Harvey BP; Bruck MJ; Mamula MJ
J Biol Chem; 2012 Feb; 287(8):5310-6. PubMed ID: 22215667
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cells acquire antigens from live cells for cross-presentation to CTL.
Harshyne LA; Watkins SC; Gambotto A; Barratt-Boyes SM
J Immunol; 2001 Mar; 166(6):3717-23. PubMed ID: 11238612
[TBL] [Abstract][Full Text] [Related]
6. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
Bodey B; Bodey B; Kaiser HE
In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
[TBL] [Abstract][Full Text] [Related]
7. A novel recycling mechanism of native IgE-antigen complexes in human B cells facilitates transfer of antigen to dendritic cells for antigen presentation.
Engeroff P; Fellmann M; Yerly D; Bachmann MF; Vogel M
J Allergy Clin Immunol; 2018 Aug; 142(2):557-568.e6. PubMed ID: 29074459
[TBL] [Abstract][Full Text] [Related]
8. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
[TBL] [Abstract][Full Text] [Related]
9. Functional Specialty of CD40 and Dendritic Cell Surface Lectins for Exogenous Antigen Presentation to CD8(+) and CD4(+) T Cells.
Yin W; Gorvel L; Zurawski S; Li D; Ni L; Duluc D; Upchurch K; Kim J; Gu C; Ouedraogo R; Wang Z; Xue Y; Joo H; Gorvel JP; Zurawski G; Oh S
EBioMedicine; 2016 Mar; 5():46-58. PubMed ID: 27077111
[TBL] [Abstract][Full Text] [Related]
10. CD40 Ligand-activated, antigen-specific B cells are comparable to mature dendritic cells in presenting protein antigens and major histocompatibility complex class I- and class II-binding peptides.
Ahmadi T; Flies A; Efebera Y; Sherr DH
Immunology; 2008 May; 124(1):129-40. PubMed ID: 18067555
[TBL] [Abstract][Full Text] [Related]
11. Stimulation by means of dendritic cells followed by Epstein-Barr virus-transformed B cells as antigen-presenting cells is more efficient than dendritic cells alone in inducing Aspergillus f16-specific cytotoxic T cell responses.
Zhu F; Ramadan G; Davies B; Margolis DA; Keever-Taylor CA
Clin Exp Immunol; 2008 Feb; 151(2):284-96. PubMed ID: 18005260
[TBL] [Abstract][Full Text] [Related]
12. DCs as targets for vaccine design.
Belz G; Smith C; Bharadwaj M; Rice A; Jackson D
Cytotherapy; 2004; 6(2):88-98. PubMed ID: 15203984
[TBL] [Abstract][Full Text] [Related]
13. Antigen capture and major histocompatibility class II compartments of freshly isolated and cultured human blood dendritic cells.
Nijman HW; Kleijmeer MJ; Ossevoort MA; Oorschot VM; Vierboom MP; van de Keur M; Kenemans P; Kast WM; Geuze HJ; Melief CJ
J Exp Med; 1995 Jul; 182(1):163-74. PubMed ID: 7790816
[TBL] [Abstract][Full Text] [Related]
14. Self- and nonself-recognition by C-type lectins on dendritic cells.
Geijtenbeek TB; van Vliet SJ; Engering A; 't Hart BA; van Kooyk Y
Annu Rev Immunol; 2004; 22():33-54. PubMed ID: 15032573
[TBL] [Abstract][Full Text] [Related]
15. Contrasting cytoskeletal regulation of MHC class II peptide presentation by human B cells or dendritic cells.
Delaguillaumie A; Marin-Esteban V; Setterblad N; Leh LJ; Assier E; Gelin C; Charron D; Galy A; Mooney N
Eur J Immunol; 2008 Apr; 38(4):1096-105. PubMed ID: 18393378
[TBL] [Abstract][Full Text] [Related]
16. Macrophage- and dendritic cell--dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF.
Craxton A; Magaletti D; Ryan EJ; Clark EA
Blood; 2003 Jun; 101(11):4464-71. PubMed ID: 12531790
[TBL] [Abstract][Full Text] [Related]
17. Absence of scavenger receptor A promotes dendritic cell-mediated cross-presentation of cell-associated antigen and antitumor immune response.
Guo C; Yi H; Yu X; Hu F; Zuo D; Subjeck JR; Wang XY
Immunol Cell Biol; 2012 Jan; 90(1):101-8. PubMed ID: 21383767
[TBL] [Abstract][Full Text] [Related]
18. CD80 and CD86 differentially regulate mechanical interactions of T-cells with antigen-presenting dendritic cells and B-cells.
Lim TS; Goh JK; Mortellaro A; Lim CT; Hämmerling GJ; Ricciardi-Castagnoli P
PLoS One; 2012; 7(9):e45185. PubMed ID: 23024807
[TBL] [Abstract][Full Text] [Related]
19. Endogenous dendritic cells are required for amplification of T cell responses induced by dendritic cell vaccines in vivo.
Kleindienst P; Brocker T
J Immunol; 2003 Mar; 170(6):2817-23. PubMed ID: 12626531
[TBL] [Abstract][Full Text] [Related]
20. Distribution and kinetics of SR-PSOX/CXCL16 and CXCR6 expression on human dendritic cell subsets and CD4+ T cells.
Tabata S; Kadowaki N; Kitawaki T; Shimaoka T; Yonehara S; Yoshie O; Uchiyama T
J Leukoc Biol; 2005 May; 77(5):777-86. PubMed ID: 15703197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]